ischemic heart disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Group of ischemic heart disease with ventricular dysfunction 2) Group of normal myocardial perfusion
Exclusion criteria
Exclusion criteria: Cardiomyopathy Valvular heart disease Severe liver dysfunction Renal dysfunction requiring hemodialysis Acute coronary syndrome within the onset of 3 months Severe arrhythmia Severe heart failure of NYHA III or IV
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse cardiac events: cardiac death, non-fatal myocardial infarction | — |
Secondary
| Measure | Time frame |
|---|---|
| Other cardiovascular events | — |
Countries
Japan
Contacts
Kanazawa University Department of Nuclear Medicine